Synthase Biotech Round 1

Investment Summary

Synthase Biotech raised this round of funds through Enterprise Angels in August 2016. For more on Synthase Biotech, visit them at http://www.synthasebiotech.com/ or login to see investors and updates.


Investment Status
SCIF Co-Funded
Completed

A major cause of product degradation and cell death in all living tissue is damage caused by the oxidation of lipids (fats) in cells. The most damaging form of this is “lipid peroxidation”. Synthase’s proprietary technology – AloxsynTM, is the only natural biological product (it is an enzyme found in a plant) known to neutralise lipid peroxides.